Sale!

CNTNAP2 Gene Cortical Dysplasia-Focal Epilepsy Syndrome Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CNTNAP2 Gene Cortical Dysplasia-Focal Epilepsy Syndrome Genetic Test” is a specialized diagnostic examination conducted to detect mutations in the CNTNAP2 gene, which are linked to the development of Cortical Dysplasia-Focal Epilepsy (CDFE) syndrome. This condition is characterized by abnormalities in the brain’s cortex that lead to epilepsy and other neurological issues. The test is a crucial tool for clinicians in diagnosing CDFE syndrome, enabling them to provide targeted treatments and management plans for affected individuals.

This genetic test is available at DNA Labs UAE, a leading facility known for its advanced diagnostic services and state-of-the-art technology. The cost of the test is 4400 AED, reflecting the sophisticated nature of the genetic analysis and the detailed insights it provides into the patient’s condition. By identifying specific mutations in the CNTNAP2 gene, this test plays a vital role in the early detection and intervention of Cortical Dysplasia-Focal Epilepsy Syndrome, offering hope and improved outcomes for patients and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome

Test Details

The CNTNAP2 gene is associated with a rare genetic disorder called Cortical dysplasia-focal epilepsy syndrome (CDFE). This disorder is characterized by abnormal brain development, which leads to seizures and other neurological symptoms.

NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze a person’s DNA. This technology allows for the simultaneous analysis of multiple genes, making it an efficient and effective way to diagnose genetic disorders like CDFE. The CNTNAP2 gene is one of many genes that may be analyzed using NGS genetic testing to diagnose CDFE. By identifying mutations or variations in this gene, healthcare providers can make a more accurate diagnosis and develop a personalized treatment plan for individuals with CDFE.

Test Name CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CNTNAP2 Gene Cortical dysplasia-focal epilepsy syndrome
Test Details

The CNTNAP2 gene is associated with a rare genetic disorder called Cortical dysplasia-focal epilepsy syndrome (CDFE). This disorder is characterized by abnormal brain development, which leads to seizures and other neurological symptoms.

NGS genetic testing is a type of genetic testing that uses next-generation sequencing technology to analyze a person’s DNA. This technology allows for the simultaneous analysis of multiple genes, making it an efficient and effective way to diagnose genetic disorders like CDFE.

The CNTNAP2 gene is one of many genes that may be analyzed using NGS genetic testing to diagnose CDFE. By identifying mutations or variations in this gene, healthcare providers can make a more accurate diagnosis and develop a personalized treatment plan for individuals with CDFE.